Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Range Cancer Therapeutics Index
(NQ:
CNCR
)
15.05
+0.28 (+1.90%)
Official Closing Price
Updated: 4:15 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Range Cancer Therapeutics Index
3 Top-Ranked ETFs Under $20 For Your Portfolio
June 07, 2024
Let us dig into some of the ETFs that are below $20 and have a strong buy rating. These low-priced ETFs could lead to huge gains in the coming months based on market trends.
Via
Talk Markets
Topics
ETFs
5 Market-Beating Sector ETFs Of Q1
March 27, 2024
Here are some of the top performers in the ETF space from different sectors of the market.
Via
Talk Markets
Topics
ETFs
5 Sector ETFs Beating The Market Halfway Through Q1
February 12, 2024
After a weak start to 2024, Wall Street regained momentum, with all three major indices logging their fifth straight week of gains.
Via
Talk Markets
Topics
ETFs
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
5 Top-Ranked ETFs To Buy At Bargain Prices For 2023
January 04, 2023
Here are five ETFs from different zones that have plunged the most over the past year but are poised to outperform when the market resumes its uptrend.
Via
Talk Markets
5 ETFs Riding High On The Biotech Comeback
July 09, 2022
The high-growth biotech segment has borne the maximum brunt of the broader market sell-off.
Via
Talk Markets
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
June 14, 2021
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.
Via
Talk Markets
Best Biotech Stocks & ETFs for mRNA, Gene Editing
April 29, 2021
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.